TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ZTS

Zoetis Inc

Healthcare · Drug Manufacturers - Specialty & Generic

71.30$ -0.1% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Cash Flow

Zoetis Inc (ZTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 655 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ZTS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
239 286 119 180 439 608 389 267 550 584 389 318 506 582 408 438 562 718 400 481 653 679 309 336 526 741 549 183 724 897 595 502 951 905 587 486 938 893 401 655 2,887
60 63 62 59 58 63 60 63 84 101 98 98 107 109 110 111 111 109 109 112 110 117 114 117 115 119 120 121 124 126 126 127 121 123 119 123 124 121 119 119 483
9.0 9.0 11 11 11 11 11 11 14 17 18 17 16 16 16 16 14 13 13 16 15 14 16 15 15 16 9.0 17 17 17 18 19 18 19 17 22 22 22 25 26 95
-20 76 54 22 21 171 -107 17 -5.0 38 17 26 -3.0 -9.0 3.0 16 45 73 16 37 -69 86 -15 16 -6.0 -77 33 21 52 – – – – – – – – – – – –
-39 -8.0 -237 -148 63 293 85 -195 123 99 -39 -177 -32 97 -129 -59 -74 177 -284 -180 59 62 -385 -326 -112 124 -155 -511 -48 202 -121 -239 360 309 -217 -415 54 170 -385 142 -19
57 60 42 51 48 83 53 73 74 138 63 103 128 166 94 90 125 144 77 113 119 168 115 146 154 171 223 166 145 198 140 132 167 216 149 178 133 161 110 117 521
-124 -59 -48 -40 -128 -54 -45 -76 -2,064 -74 -23 -59 -209 -213 -57 -164 -174 -177 -63 -139 -114 -142 -118 -203 -124 -438 -216 -80 -567 -210 -131 -132 -178 126 -175 -247 -160 -166 -87 -300 -713
47 47 52 51 52 51 62 60 61 60 79 78 78 79 95 95 95 95 119 119 119 117 154 153 153 151 174 173 173 172 198 197 197 194 224 223 222 220 224 223 889
-74 -75 -125 -125 -125 -125 -190 -215 -143 -150 -150 -150 -150 -176 -250 1.0 8.0 250 -181 -166 -198 -198 -361 -451 -377 -405 -283 -324 -250 -235 -339 -533 -433 -553 -443 -338 -394 -2,060 -606 -584 -3,644
-4.0 -3.0 100 100 1,131 -750 1,485 1,485 1,485 8.0 -9.0 – 1,241 1,241 1,241 1,229 -497 -497 -604 -604 -604 2.0 2.0 2.0 1.0 1,337 -1,349 -1.0 – – – – 0.0 0.0 0.0 0.0 498 2,000 – – –
-124 -128 -176 -64 956 -967 -262 -271 1,263 -197 -243 -226 -232 -250 -328 1,141 -93 -597 -339 -290 -919 -314 -545 -610 -529 780 -1,802 -494 -416 -397 -524 -763 -628 -745 -677 -564 -134 -495 -840 -813 -2,282
-7.0 76 -98 76 1,276 -417 90 -96 -272 316 126 27 60 119 17 1,402 301 -50 -2.0 56 -384 211 -350 -483 -145 1,074 -1,472 -392 37 287 -66 -401 140 273 -266 -286 649 228 -509 -465 -97
182 226 77 129 391 525 336 194 476 446 326 215 378 416 314 348 437 574 323 368 534 511 194 190 372 570 326 17 579 699 455 370 784 689 438 308 805 732 291 538 2,366

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?